TP53 and neoplasm: In this study, SFN-NLP administration further corroborated previous findings by significantly enhancing apoptosis, as evidenced by the downregulation of the anti-apoptotic gene Bcl-2 and the upregulation of pro-apoptotic genes (TP53 and Bax) in tumor tissues.